Statement from the REMAP-CAP trial
Statement from the REMAP-CAP trial: International Trials of Blood Thinners Pause Enrolment of Critically Ill COVID-19 Patients Three clinical trial platforms…
Statement from the REMAP-CAP trial: International Trials of Blood Thinners Pause Enrolment of Critically Ill COVID-19 Patients Three clinical trial platforms…
AF Association Healthcare Pioneers Report: Showcasing best practice in AF 2021: Today, to mark the start of Global AF Aware Week…
The Top Journal Lancet Haematology recently published an international trial on a blood thinner to treat blood clots in children.…
This website uses cookies.